SCHEMBL7084672

SCHEMBL7084672

Cc1cn(C)nc1-c1ccnc(Nc2ccc(O)c([N+](=O)[O-])c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 7/20 0.47
CDK4 P11802 5/20 0.47
PLK1 P53350 2/20 0.44
AURKB Q96GD4 2/20 0.44
KDR P35968 1/20 0.44
PTK2 Q05397 1/20 0.44
ALDH1A1 P00352 1/20 0.43
ABCG2 Q9UNQ0 3/20 0.42
ABCC1 P33527 1/20 0.42
IKBKB O14920 1/20 0.42
ABL1 P00519 3/20 0.42
BCR P11274 2/20 0.42
PRKCA P17252 2/20 0.42
PIK3CA P42336 2/20 0.41
PIK3CB P42338 2/20 0.41
PIK3CG P48736 2/20 0.41
CCNT1 O60563 2/20 0.40
CDK1 P06493 2/20 0.40
CCNB1 P14635 2/20 0.40
CDK9 P50750 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14254276 0.78 PIK3CA (0.51) CDK2CDK4PLK1ALDH1A1ABCG2
SCHEMBL7084675 0.78 CDK2 (0.52) CDK2CDK4PLK1AURKBALDH1A1
SCHEMBL6158465 0.77 CDK2 (0.75) CDK2CDK4PLK1AURKBABL1
SCHEMBL6157065 0.74 CDK2 (0.70) CDK2CDK4PLK1AURKBKDR
SCHEMBL14254270 0.74 SRC (0.50) CDK2CDK4PLK1IKBKBABL1
SCHEMBL14254260 0.72 DKK1 (0.59) PLK1ABCG2ABCC1IKBKBABL1
SCHEMBL14254274 0.72 ABCG2 (0.54) CDK2CDK4PLK1AURKBKDR
SCHEMBL14254267 0.72 PIK3CA (0.53) CDK2PLK1ABCG2IKBKBABL1
SCHEMBL14254254 0.72 PIK3CA (0.68) CDK2CDK4PLK1ABCG2IKBKB
SCHEMBL14254259 0.71 CAMK2D (0.61) CDK2CDK4PLK1ABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1274705-A1 2-SUBSTITUTED 4-HETEROARYL-PYRIMIDINES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2003-01-15 EP disclosed
WO-2001072745-A1 2-SUBSTITUTED 4-HETEROARYL-PYRIMIDINES AND THEIR USE IN THE TREATMETN OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2001-10-04 WO disclosed